Publications found:
36,694
Sort by:
Diabetic Cardiomyopathy - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Diabetic Cardiomyopathy - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease...
January 2022
60 pages
Diabetic Eye Disease - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Diabetic Eye Disease - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, h...
January 2022
60 pages
Diabetic Foot - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Diabetic Foot - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historic...
January 2022
60 pages
Diabetic Hypoglycemia - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Diabetic Hypoglycemia - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease,...
January 2022
60 pages
Digestive System Fistula - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Digestive System Fistula - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the diseas...
January 2022
60 pages
Dipeptidyl peptidase 4 inhibitors - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Dipeptidyl Peptidase 4 Inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 8+ companies and...
January 2022
60 pages
Diphtheria - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Diphtheria - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical...
January 2022
60 pages
DNA gyrase inhibitors - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “DNA gyrase inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 12+ companies and 13+ pipeli...
January 2022
60 pages
DNA topoisomerase I inhibitors - Pipeline Insight, 2022
US$ 2,000.00
This report can be delivered to the clients within 3-4 Business Days DelveInsight’s, “DNA topoisomerase I inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 20+ compan...
January 2022
80 pages
DNA topoisomerase inhibitors - Pipeline Insight, 2022
US$ 2,000.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “DNA topoisomerase inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 20+ companies and 20+...
January 2022
80 pages
Doose Syndrome - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Doose Syndrome - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histori...
January 2022
60 pages
Dopamine D1 receptor antagonists - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “Dopamine D1 Receptor Antagonists - Pipeline Insight, 2022” report provides comprehensive insights about 3+ companies and...
January 2022
60 pages
Dopamine receptor antagonists - Pipeline Insight, 2022
US$ 2,000.00
This report can be delivered to the clients within 2-3 working days DelveInsight’s, “Dopamine receptor antagonists - Pipeline Insight, 2022” report provides comprehensive insights about 25+ companie...
January 2022
60 pages
Down Syndrome - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Down Syndrome - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historic...
January 2022
60 pages
Dravet Syndrome (DS) - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Dravet Syndrome (DS) - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, h...
January 2022
60 pages
Dravet Syndrome - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Dravet Syndrome - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histor...
January 2022
60 pages
Drug Hypersensitivity - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Drug Hypersensitivity - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease,...
January 2022
60 pages
Drug Resistant Epilepsy - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Drug Resistant Epilepsy - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease...
January 2022
60 pages
Ductal Carcinoma in Situ - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Ductal Carcinoma in Situ - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the diseas...
January 2022
60 pages
Dup15q Syndrome - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Dup15q Syndrome - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histor...
January 2022
60 pages
Dupuytren Contracture - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Dupuytren Contracture - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease,...
January 2022
60 pages
DUX4 protein inhibitors - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “DUX4 protein inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 3+ companies and 3+ pipeli...
January 2022
60 pages
Dyschromia - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Dyschromia - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical...
January 2022
60 pages
